Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI109763

Protection from Oxygen Toxicity with Endotoxin: ROLE OF THE ENDOGENOUS ANTIOXIDANT ENZYMES OF THE LUNG

L. Frank, J. Summerville, and D. Massaro

The Pulmonary Toxicology Laboratory, Veterans Administration Hospital, Miami, Florida 33101

Calvin and Flavia Oak Asthma Research Center, University of Miami School of Medicine, Miami, Florida 33101

Find articles by Frank, L. in: PubMed | Google Scholar

The Pulmonary Toxicology Laboratory, Veterans Administration Hospital, Miami, Florida 33101

Calvin and Flavia Oak Asthma Research Center, University of Miami School of Medicine, Miami, Florida 33101

Find articles by Summerville, J. in: PubMed | Google Scholar

The Pulmonary Toxicology Laboratory, Veterans Administration Hospital, Miami, Florida 33101

Calvin and Flavia Oak Asthma Research Center, University of Miami School of Medicine, Miami, Florida 33101

Find articles by Massaro, D. in: PubMed | Google Scholar

Published May 1, 1980 - More info

Published in Volume 65, Issue 5 on May 1, 1980
J Clin Invest. 1980;65(5):1104–1110. https://doi.org/10.1172/JCI109763.
© 1980 The American Society for Clinical Investigation
Published May 1, 1980 - Version history
View PDF
Abstract

Endotoxin treatment of adult rats before hyperoxic exposure significantly increases their survival rate in >95% O2 (J. Clin. Invest.61: 269, 1978). In this study, we wished to determine: (a) whether endotoxin would protect against O2 toxicity if it were administered after the animals were already in >95% O2 for 12-48 h; and (b) the relationship between the endogenous antioxidant enzymes of the lung and the protective effect of endotoxin treatment.

Our results showed that adult rats given a single 500 μg/kg dose of endotoxin up to 36 h after the onset of O2 exposure had significantly increased survival rates and decreased lung fluid accumulation compared to untreated animals in O2 (P < 0.05). (Survival, 16/49 [untreated rats]; 18/20 [endotoxin at 12 h after the start of O2 exposure]; 25/26 [endotoxin-24 h]; 15/20 [endotoxin-36 h].)

Endotoxin-treated animals in O2 showed increases in pulmonary superoxide dismutase, catalase, and glutathione peroxidase activities before the usual time of onset of measurable pulmonary edema in untreated animals in O2. When diethyldithiocarbamate was used to block the superoxide dismutase enzyme rise in the endotoxin-treated rats in O2, the protective action of endotoxin against pulmonary O2 toxicity was nullified. In endotoxin-treated, O2-exposed mice, there were no lung antioxidant enzyme increases, and no protective effect from O2 toxicity was achieved.

We conclude that, in the rat, a single dose of endotoxin given even 36 h after the onset of hyperoxic exposure results in marked protection against O2-induced lung damage; and the increased lung antioxidant enzyme activity in the endotoxin-treated rats appears to be an essential component of this protective action.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1104
page 1104
icon of scanned page 1105
page 1105
icon of scanned page 1106
page 1106
icon of scanned page 1107
page 1107
icon of scanned page 1108
page 1108
icon of scanned page 1109
page 1109
icon of scanned page 1110
page 1110
Version history
  • Version 1 (May 1, 1980): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts